Related Experiment Video
Updated: Jan 14, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
Unlocking Potential of Generative Large Language Models for Adverse Drug Reaction Relation Prediction in Discharge
Yen Ling Koon1, Hui Xing Tan1, Desmond Chun Hwee Teo1
1Vigilance & Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore.
Abstract:
We present a comparative analysis of generative large language models (LLMs) for predicting causal relationships between drugs and adverse events found in text segments from discharge summaries. Despite lacking prior training for identifying related drug-adverse event pairs, generative LLMs demonstrate exceptional performance as recall-optimized models, achieving F1 scores comparable to those of fine-tuned models. Notably, on the MIMIC-Unrestricted dataset, Gemini 1.5 Pro and Llama 3.1 405B outperform our in-house fine-tuned BioM-ELECTRA-Large, with Gemini 1.5 Pro showing a 19.2% (0.724-0.863) improvement in F1 score and a 39.7% (0.675-0.943) increase in recall, while Llama 3.1 405B exhibits a 12.4% (0.724-0.814) improvement in F1 and a 40.4% (0.675-0.948) boost in recall. Additionally, we propose a hybrid approach that integrates BioM-ELECTRA-Large with generative LLMs, resulting in enhanced performance over the individual models. Our hybrid model achieves F1 score improvements ranging from 0.8% to 18.5% (0.005-0.133) over BioM-ELECTRA-Large in the validation set, primarily due to increased precision, albeit with a decrease in recall compared with the original generative LLM. Importantly, this approach yields substantial computational resource savings, as BioM-ELECTRA-Large selects only a subset of segments-ranging from 19.7% to 73.4% across our datasets-for downstream prediction by generative LLMs. By harnessing the strengths of generative LLMs as recall-optimized models and combining them with fine-tuned models, we can unlock the full potential of artificial intelligence in predicting adverse drug reaction relations, ultimately enhancing patient safety.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Discovery: Overview
Predicting Reaction Outcomes
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Analysis of Population Pharmacokinetic Data
Factors Affecting Drug Response: Overview

